Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events

Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events

Immune checkpoint inhibitors (ICIs) have been proven to be beneficial in multiple advanced malignancies. However, the widespread use of ICIs also occurred with various immune-related adverse events (irAEs). Here, we first report a case of sintilimab-related cystitis/ureteritis. A 53-year-old man wit...

Full description

Bibliographic Details
Main Authors: Lingfang Tu, Yuan Ye, Xiaoping Tang, Zhen Liang, Qihan You, Jianying Zhou, Zhijie Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitor
sintilimab
immune-related adverse events
cystitis
ureteritis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.757069/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.757069/full

Similar Items